Chitose Oneyama Selected Research

Chitose Oneyama Research Topics

Disease

22	Neoplasms (Cancer) 04/2022 - 05/2006
3	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2006
3	Colonic Neoplasms (Colon Cancer) 07/2018 - 10/2010
2	Carcinoma (Carcinomatosis) 01/2015 - 05/2006
1	Pathologic Processes 10/2022
1	Kidney Neoplasms (Kidney Cancer) 04/2022
1	Lymphoma (Lymphomas) 01/2021
1	Triple Negative Breast Neoplasms 10/2020
1	Carcinogenesis 04/2019
1	Lung Neoplasms (Lung Cancer) 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017
1	Osteosarcoma (Osteogenic Sarcoma) 01/2012
1	Inflammation (Inflammations) 03/2007
1	Hyperplasia 03/2007
1	Glioblastoma (Glioblastoma Multiforme) 05/2006
1	Breast Neoplasms (Breast Cancer) 05/2006

Drug/Important Bio-Agent (IBA)

10	CSK Tyrosine-Protein KinaseIBA 02/2020 - 03/2007
5	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2011
4	src-Family KinasesIBA 09/2017 - 03/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 05/2011
2	LuciferasesIBA 04/2022 - 01/2022
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2015
2	PaxillinIBA 07/2018 - 01/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2017 - 10/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2015 - 01/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2022
1	Biological ProductsIBA 10/2022
1	Membrane LipidsIBA 10/2022
1	asteltoxinIBA 01/2022
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2022
1	pyrimidineIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Hormones (Hormone)IBA 10/2020
1	Epidermal Growth Factor (EGF)IBA 10/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2019
1	Messenger RNA (mRNA)IBA 07/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	AfatinibIBA 09/2017
1	osimertinibIBA 09/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2017
1	ErbB Receptors (EGF Receptor)IBA 09/2017
1	GTP Phosphohydrolases (GTPases)IBA 04/2016
1	Mevalonic Acid (Mevalonate)IBA 04/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	IntegrinsIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2012
1	Matrix Metalloproteinase 13IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Mitogen-Activated Protein KinasesIBA 05/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2011
1	Carrier Proteins (Binding Protein)IBA 05/2011
1	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 10/2010
1	Growth Factor ReceptorsIBA 10/2010
1	Cyclin D1IBA 01/2008
1	Indicators and Reagents (Reagents)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2007
1	Pharmaceutical PreparationsIBA 05/2006
1	Peptides (Polypeptides)IBA 05/2006
1	CortactinIBA 05/2006
1	UCS15AIBA 05/2006
1	Proline (L-Proline)FDA Link 05/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2006
1	Transplantation 10/2020
1	Drug Therapy (Chemotherapy) 04/2016